Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.48 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.48 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.48 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3176008 | 0.97 | PRMT3 (0.46) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL4822946 | 0.85 | PRMT3 (0.35) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL9404552 | 0.83 | TDP1 (0.44) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL14176492 | 0.82 | CA12 (0.33) | CA2CA12CA9TSHRCA3 | |
| SCHEMBL13615260 | 0.81 | ALDH1A1 (0.48) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL13792394 | 0.79 | ALDH1A1 (0.52) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL14195466 | 0.79 | ALDH1A1 (0.52) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL17708254 | 0.79 | — | — | |
| SCHEMBL18402846 | 0.78 | PRMT3 (0.31) | PRMT3CARM1PRMT6PRMT1PRMT8 | |
| SCHEMBL24245920 | 0.78 | PRMT3 (0.43) | PRMT3CARM1PRMT6PRMT1PRMT8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 340 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0973514-A1 | $i(IN VIVO) POLYMERIZABLE OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 2000-01-26 | — | — | EP | claimed |
| US-5858345-A | In vivo polymerizable ophthalmic compositions | ALCON LABORATORIES, INC. (US) | 1999-01-12 | — | — | US | claimed |
| WO-1998044915-A1 | IN VIVO POLYMERIZABLE OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1998-10-15 | — | — | WO | claimed |
| EP-0272562-B1 | Basic adhesive polymeric mass transmitting the active ingredient, method for making it and its use | LOHMANN THERAPIE SYST LTS (DE) | 1994-03-09 | — | — | EP | claimed |
| US-20260049397-A1 | METHOD FOR MANUFACTURING ALUMINUM-DOPED THIN FILM USING 4-COORDINATE ALUMINUM PRECURSOR | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2026-02-19 | — | — | US | disclosed |
| US-20260047145-A1 | STACKED MULTI-CHANNEL STRUCTURE AND METHOD FOR MANUFACTURING SAME, AND THIN FILM TRANSISTOR COMPRISING SAME | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ) (KR) | 2026-02-12 | — | — | US | disclosed |
| EP-4527972-A1 | NOVEL COMPOSITION, PRECURSOR COMPOSITION INCLUDING SAME, AND METHOD OF MANUFACTURING THIN FILM USING SAME PRECURSOR COMPOSITION | Hansol Chemical Co., Ltd (KR) | 2025-03-26 | — | — | EP | disclosed |
| US-20250066914-A1 | NOVEL COMPOSITION, PRECURSOR COMPOSITION INCLUDING SAME, AND METHOD OF MANUFACTURING THIN FILM USING SAME PRECURSOR COMPOSITION | HANSOL CHEMICAL CO., LTD (KR) | 2025-02-27 | — | — | US | disclosed |
| WO-2024219728-A1 | STACKED MULTI-CHANNEL STRUCTURE AND METHOD FOR MANUFACTURING SAME, AND THIN FILM TRANSISTOR COMPRISING SAME | 한양대학교 산학협력단 | 2024-10-24 | — | — | WO | disclosed |
| US-12030867-B2 | Hsp90β selective inhibitors | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2024-07-09 | — | — | US | disclosed |
| CN-111727271-B | Method for producing metal-containing films | 巴斯夫欧洲公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2023239152-A1 | THIN FILM PRECURSOR COMPOUND, METHOD FOR FORMING THIN FILM BY USING SAME, AND SEMICONDUCTOR SUBSTRATE MANUFACTURED THEREBY | 솔브레인 주식회사 | 2023-12-14 | — | — | WO | disclosed |
| US-6342621-B1 | ACTIVE IN RING-OPENING POLYMERIZATION OF CYCLIC OLEFIN MONOMERS WITHOUT REQUIRING THE PRESENCE OF CO-CATALYST SUCH AS DIAZO ALKYL COMPOUND | NIPPON ZEON CO., LTD. (JP) | 2002-01-29 | — | — | US | disclosed |
| US-6180687-B1 | IN SITU REPAIRING DETACHED RETINAL TISSUE | ALCON LABORATORIES, INC. | 2001-01-30 | — | — | US | disclosed |
| US-6124037-A | SURGICAL INSTRUMENT WITH COATING OF POLYMERIZABLE MONOMER SUCH AS (PER)FLUOROALKYL ETHER-SUBSTITUTED HYDROXYMETHACRYLIC ACID AND ITS ESTERS AND AMIDES, INCLUDING ETHOXYLATED, ALKYL AMMONIUM, AND POLYOL SUBSTITUENTS; COATED OPHTHALMIC DEVICE | ALCON LABORATORIES, INC. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-1024144-A2 | Ruthenium catalysts for metathesis reactions of olefins | ZEON CHEMICALS L.P. (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-0973514-A1 | $i(IN VIVO) POLYMERIZABLE OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 2000-01-26 | — | — | EP | disclosed |
| US-5858345-A | In vivo polymerizable ophthalmic compositions | ALCON LABORATORIES, INC. (US) | 1999-01-12 | — | — | US | disclosed |
| WO-1998044915-A1 | IN VIVO POLYMERIZABLE OPHTHALMIC COMPOSITIONS | ALCON LABORATORIES, INC. (US) | 1998-10-15 | — | — | WO | disclosed |
| EP-0021569-A1 | Amino-terminated polymers, process for their preparation and their use | Interox Chemicals Limited (GB) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260047145-A1 | STACKED MULTI-CHANNEL STRUCTURE AND METHOD FOR MANUFACTURING SAME, AND THIN FILM TRANSISTOR COMPRISING SAME | CACNA1S, CACNA1H, LATS1 | PRMT3 4391/4885CARM1 2904/4885PRMT6 4349/4885 |
| US-20250066914-A1 | NOVEL COMPOSITION, PRECURSOR COMPOSITION INCLUDING SAME, AND METHOD OF MANUFACTURING THIN FILM USING SAME PRECURSOR COMPOSITION | ADH1C, APOB, ADH1A | PRMT3 4224/4885CARM1 4012/4885PRMT6 3670/4885 |
| US-12030867-B2 | Hsp90β selective inhibitors | HSP90AB1, HSP90B1, HSP90AB2P | PRMT3 4291/4885CARM1 3572/4885PRMT6 4446/4885 |
| US-20260049397-A1 | METHOD FOR MANUFACTURING ALUMINUM-DOPED THIN FILM USING 4-COORDINATE ALUMINUM PRECURSOR | TERF2, NT5C, POT1 | PRMT3 2720/4885CARM1 1950/4885PRMT6 2276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.